Financière de Tubize SA (EBR:TUB)
Belgium · Delayed Price · Currency is EUR 207.80
0.00 (0.00%)
May 22, 2026, 5:35 PM CET
Financière de Tubize Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 13.26K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 8.15K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 7.74B |
| argenx SE | 4.11B |
| European Medical Solutions | 52.80M |
| Hyloris Pharmaceuticals | 8.83M |
| Onward Medical | 5.41M |
| Celyad Oncology | 21.00K |
| Oxurion NV | 2.00K |
| BioSenic | -2.39M |
Financière de Tubize News
- 2 months ago - Financière de Tubize Earnings Call Transcript: H2 2025 - Transcripts
- 2 months ago - Financière de Tubize Annual report: H2 2025 - Filings
- 2 months ago - Financière de Tubize Earnings Call Transcript: H2 2025 - Transcripts
- 2 months ago - Financière de Tubize Annual report: H2 2025 - Filings
- 10 months ago - Financière de Tubize Earnings release: H1 2025 - Filings
- 10 months ago - Financière de Tubize Quarterly report: H1 2025 - Filings
- 10 months ago - Financière de Tubize Earnings release: H1 2025 - Filings
- 10 months ago - Financière de Tubize Quarterly report: H1 2025 - Filings